| Literature DB >> 32997203 |
Marine Lénon1,2, Na Ke1, Cecily Szady1, Hassan Sakhtah1,3, Guoping Ren1, Bruno Manta1,4, Bryce Causey1, Mehmet Berkmen5.
Abstract
Microbial production of antibodies offers the promise of cheap, fast, and efficient production of antibodies at an industrial scale. Limiting this capacity in prokaryotes is the absence of the post-translational machinery, present in dedicated antibody producing eukaryotic cell lines, such as B cells. There has been few and limited success in producing full-length, correctly folded, and assembled IgG in the cytoplasm of prokaryotic cell lines. One such success was achieved by utilizing the genetically engineered Escherichia coli strain SHuffle with an oxidative cytoplasm. Due to the genetic disruption of reductive pathways, SHuffle cells are under constant oxidative stress, including increased levels of hydrogen peroxide (H2O2). The oxidizing capacity of H2O2 was linked to improved disulfide bond formation, by expressing a fusion of two endoplasmic reticulum-resident proteins, the thiol peroxidase GPx7 and the protein disulfide isomerase, PDI. In concert, these proteins mediate disulfide transfer from H2O2 to target proteins via PDI-Gpx7 fusions. The potential of this new strain was tested with Humira, a blockbuster antibody usually produced in eukaryotic cells. Expression results demonstrate that the new engineered SHuffle strain (SHuffle2) could produce Humira IgG four-fold better than the parental strain, both in shake-flask and in high-density fermentation. These preliminary studies guide the field in genetically engineering eukaryotic redox pathways in prokaryotes for the production of complex macromolecules. KEY POINTS: • A eukaryotic redox pathway was engineered into the E. coli strain SHuffle in order to improve the yield of the blockbuster antibody Humira. • The best peroxidase-PDI fusion was selected using bioinformatics and in vivo studies. • Improved yields of Humira were demonstrated at shake-flask and high-density fermenters.Entities:
Keywords: Disulfide bond; E. coli; GPx7; Humira production; PDI; Redox engineering; SHuffle
Mesh:
Substances:
Year: 2020 PMID: 32997203 PMCID: PMC7595990 DOI: 10.1007/s00253-020-10920-5
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813
Bacterial strains and plasmids utilized in this study
SHuffle express T7 (C3029) | NEB cat# C3029 | ||
| MB2797 | C3029 + pBAD34 - KatG-FLAG | This study | |
| MB4638 | C3029 + pACYC Duet | This study | |
| MB6226 | C3029 + pACYC Duet - PDI-hsa Gpx7-Flag (SHuffle2) | This study | |
| MB6227 | C3029 + pACYC Duet - PDI-mmu Gpx7-Flag | This study | |
| MB6228 | C3029 + pACYC Duet - PDI-dre Gpx7-Flag | This study | |
| MB6229 | C3029 + pACYC Duet - PDI-lak Gpx7-Flag | This study | |
| MB6230 | C3029 + pACYC Duet - PDI-aqu Gpx7-Flag | This study | |
| MB6231 | C3029 + pACYC Duet - PDI-gga Gpx7-Flag | This study | |
| MB6232 | C3029 + pACYC Duet - PDI-pxb Gpx7-Flag | This study | |
| MB6233 | C3029 + pACYC Duet - cPDI-Gpx7-Flag | This study | |
| MB6165 | C3029 + pACYC Duet | + pET23b | This study |
| MB4135 | C3029 | + pHumira | This study |
| MB6209 | C3029 + pACYC Duet | + pHumira | This study |
| MB6201 | C3029 + pACYC Duet - PDI-hsa Gpx7 | + pHumira (SHuffle2) | This study |
| MB6202 | C3029 + pACYC Duet - PDI-mmu Gpx7 | + pHumira | This study |
| MB6203 | C3029 + pACYC Duet - PDI-dre Gpx7 | + pHumira | This study |
| MB6204 | C3029 + pACYC Duet - PDI-lak Gpx7 | + pHumira | This study |
| MB6205 | C3029 + pACYC Duet - PDI-aqu Gpx7 | + pHumira | This study |
| MB6206 | C3029 + pACYC Duet - PDI-gga Gpx7 | + pHumira | This study |
| MB6207 | C3029 + pACYC Duet - PDI-pxb Gpx7 | + pHumira | This study |
| MB6208 | C3029 + pACYC Duet - cPDI-Gpx7 | + pHumira | This study |
| MB6210 | C3029 + pACYC Duet - Gpx7-hsa-Flag | + pHumira | This study |
| pHumira | Humira antibody cloned into pETDuet NdeI/XhoI site by Gibson Assembly of PCR product of LC and HC, under the regulation of T7 promoter, pBR322 origin, AmpR. | (Leith et al. | |
| pACYC Duet | Vector encodes two multiple cloning sites (MCS) under the control of T7 promoter, lac operator and ribosome binding site. pACYC origin, CamR. | Novagen cat# 71146–3 | |
| pACYC Duet-PDI-lak GPx7-FLAG | This study | ||
| pACYC Duet-PDI-pxb GPx7-FLAG | This study | ||
| pACYC Duet-PDI-aqu GPx7-FLAG | This study | ||
| pACYC Duet-PDI-dre GPx7-FLAG | This study | ||
| pACYC Duet-PDI-gga GPx7-FLAG | This study | ||
| pACYC Duet-PDI-hsa GPx7-FLAG | This study | ||
| pACYC Duet-PDI-mmu GPx7-FLAG | This study | ||
| pACYC Duet-hsa-GPx7- FLAG | This study | ||
Fig. 1Schematic representation of the redox pathway in SHuffle2. Genetic deletions of gor and trxB genes disrupt the electron flow (dotted lines) to the glutathione (Grx) and thioredoxin (Trx) reductases, resulting in lethality. Suppressors are mapped to the mutant peroxidase AhpC*, which has lost its peroxidase activity and instead has gained the ability to reduce Grx1. Oxidized thioredoxin (Trx1) facilitates the oxidation of proteins, which are further isomerized by the cytoplasmic expression of disulfide bond isomerase, DsbC. The lack of peroxidase activity of AhpC* results in accumulation of H2O2. Expression of PDI-GPx7 fusions (here shown as separate proteins for clarity) results in the oxidation of GPx7 by H2O2, which in turn oxidizes PDI who can then participate oxidation
Fig. 2Selection of GPx7 homologs. a Phylogenetic distribution of GPx7 homologs and selected candidates are indicated. The percentage amino acid sequence identity to human GPx7 is shown in brackets. b Representative view of the phylogeny from the selected GPx7 homologs. The FastTree was made without branch length from the eight Gpx7 homolog sequences. c Schematic representation of the pACYC Duet vector expressing the PDI-GPx7 fusions. PDI and GPx7 peroxidases were fused by a poly-linker of 17 amino acids and cloned under the regulation of a T7 promoter with a C-terminal 3X Flag tag
Fig. 3SHuffle expressed Gpx7-PDI fusions are soluble. SHuffle cells expressing various PDI-GPx7 fusions were lysed by sonication (total fraction, T) and the insoluble fraction was removed by centrifugation, separating the soluble supernatant fraction (S). Cells expressing empty vector was used as negative control (lane 1) and cells expressing flag-tagged KatG (83 kDa) was used as a positive control for the western blot (lane 2). Samples were separated by SDS-PAGE blotted on nitrocellulose paper and probed with anti-Flag antibodies. The molecular weight of the protein ladder is shown in the left. Protein bands at the expected size of the fusions are shown in red boxes (lanes 3 to 18)
Fig. 4Redox states of SHuffle expressed Gpx7-PDI fusions. SHuffle cells expressing various PDI-GPx7 fusions were precipitated with TCA and pellets were either resuspended in loading buffer representing the fully oxidized species (lanes 2, 5, 8, 11, 14, 17, 21, 24) or samples were first reduced with DTT followed by AMS alkylation representing the fully reduced species (lanes 1, 4, 7, 10, 13, 16, 19, 23). Redox state of the fusions was evaluated by resuspending the samples in loading buffer with AMS (lanes 3, 6, 9, 12, 15, 18, 22, 25). The number of cysteines in the fusions is shown
Fig. 5SHuffle expression of Humira IgG is improved by Gpx7-PDI fusions. a Effects of PDI-GPx7 fusions on the folding of Humira IgG is evaluated by protein A purification from soluble SHuffle lysates grown in shake-flask conditions. Samples were separated in non-reducing SDS-PAGE. The expected size of Humira IgG (150 kDa) is indicated with an arrow. Data are representative of three independent experiments. b Evaluation of PDI-GPx7 fusions on the Humira IgG folding conducted by quantifying the intensity of the band representing Humira to a contaminating band used to normalize loading amounts (*), (n = 3). One-way ANOVA with alpha = 0.05, *** p value ≤ 0.001, ** p value ≤ 0.01, * p value ≤ 0.05. c Yields of protein A purified Humira antibody, produced in SHuffle or SHuffle2 strains grown in shake flasks from three independent cultures (n = 3). Unpaired t test with alpha = 0.05, ** p value ≤ 0.01
Fig. 6High-density fermentation of Humira IgG expression is improved in SHuffle2. a Expression of Humira IgG was evaluated in SHuffle cells harboring empty vector (MB4135 lanes 1–3), in SHuffle cells expressing Humira IgG (MB6209, lanes 7–8), or in SHuffle2 cells expressing Humira IgG and co-expressing human PDI-Gpx7 fusion (MB6201, lanes 4–6). Purified Humira IgG was analyzed in SDS-PAGE under non-denaturing conditions. Full length correctly assembled IgG and unassembled Heavy Chain (HC) and Light Chain (LC) are indicated by arrows. b Humira IgG yields from wild type SHuffle cells (wt, MB4135), SHuffle control cells carrying the pACYC Duet plasmid (SH, MB6209), and SHuffle2 cells (SH2, MB6201) grown in high-density from two or three independent cultures